1. Profiling of β-Lactam Selectivity for Penicillin-Binding Proteins in Escherichia coli Strain DC2
- Author
-
Ozden Kocaoglu and Erin E. Carlson
- Subjects
Penicillin binding proteins ,Cefotaxime ,Microbial Sensitivity Tests ,Aztreonam ,beta-Lactams ,medicine.disease_cause ,chemistry.chemical_compound ,Escherichia coli ,polycyclic compounds ,medicine ,Penicillin-Binding Proteins ,Pharmacology (medical) ,Mecillinam ,Pharmacology ,Gel electrophoresis ,chemistry.chemical_classification ,Cefuroxime ,Amdinocillin ,biochemical phenomena, metabolism, and nutrition ,Anti-Bacterial Agents ,Penicillin ,Infectious Diseases ,Enzyme ,chemistry ,Biochemistry ,bacteria ,medicine.drug - Abstract
Penicillin-binding proteins (PBPs) are integral players in bacterial cell division, and their catalytic activities can be monitored with β-lactam-containing chemical probes. Compounds that target a single PBP could provide important information about the specific role(s) of each enzyme, making identification of such molecules important. We evaluated 22 commercially available β-lactams for inhibition of the PBPs in live Escherichia coli strain DC2. Whole cells were titrated with β-lactam antibiotics and subsequently incubated with a fluorescent penicillin derivative, Bocillin-FL (Boc-FL), to label uninhibited PBPs. Protein visualization was accomplished by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) separation and fluorescent scanning. The examined β-lactams exhibited diverse PBP selectivities, with amdinocillin (mecillinam) showing selectivity for PBP2, aztreonam, piperacillin, cefuroxime, cefotaxime, and ceftriaxone for PBP3, and amoxicillin and cephalexin for PBP4. The remaining β-lactams did not block any PBPs in the DC2 strain of E. coli or inhibited more than one PBP at all examined concentrations in this Gram-negative organism.
- Published
- 2015
- Full Text
- View/download PDF